Insider · CIK 0001768337
Ronald Todd Plott
Files at PHIO (Phio Pharmaceuticals Corp.). First filing Aug 20, 2026, latest Sep 30, 2026.
In brief
Ronald Todd Plott files SEC Form 4 as director at PHIO (Phio Pharmaceuticals Corp.). Since Aug 20, 2026, Ronald Todd Plott has reported 2 open-market buys worth $27k and 0 open-market sells worth $0, the latest filed on Sep 30, 2026.
A track record needs three past buys with six months of prices behind them; Ronald Todd Plott has 0, so none is measured yet.
The newest scored trade: bought $10k of PHIO on Sep 28, 2026, filed Sep 30, 2026, scored 36 (weak). In the last 12 months: 2 buys worth $27k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PHIO: Phio Pharmaceuticals Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Phio Pharmaceuticals Corp. | $10k 10,000 shares | +31% | - | |
| 39Weak | Phio Pharmaceuticals Corp. | $17k 15,000 shares | - | +34% from low-54% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +5,000 | $1.03 | $5,150 | 37,000 | 14 d ago |
| Sep 29, 2026 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +5,000 | $1.04 | $5,200 | 42,000 | 14 d ago |
| Sep 28, 2026 | PHIO Phio Pharmaceuticals Corp. | AGrant or award Common Stock, $.0001 par value | +17,000 | $0.00 | $0 | 32,000 | 15 d ago |
| Aug 19, 2026 | PHIO Phio Pharmaceuticals Corp. | POpen-market purchase Common Stock, $.0001 par value | +15,000 | $1.14 | $17k | 15,000 | Aug 20, 2026 |
Questions about Ronald Todd Plott
Answered from the filings on this page, as of the latest one.
Is Ronald Todd Plott buying or selling?
In the last 12 months Ronald Todd Plott reported 2 open-market buys worth $27k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $10k of PHIO on Sep 28, 2026. Grants, option exercises and tax withholding are not counted.
How did Ronald Todd Plott's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald Todd Plott has 0.
Where does Ronald Todd Plott file Form 4?
Ronald Todd Plott has filed Form 4 at PHIO (Phio Pharmaceuticals Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.